Ankylosing spondylitis (AS) | sciencenewsnet.in

Breaking News

Tailbone Pain Awareness Day (Nov. 13): Shedding Light on a Commonly Overlooked Condition

Probing Neutron Star Crusts with Artificial Neural Networks

New Report Examines Barriers to Oral Health Services for New Yorkers

Setting New Research Vision for Cedars-Sinai Guerin Children’s

Is Weight Loss Surgery right for me?

Anti-Inflammatory and Neuroprotective Polyphenols Derived from the European Olive Tree, Olea europaea L., in Long COVID and Other Conditions Involving Cognitive Impairment

Cohesin RAD21 Gene Promoter Methylation in Patients with Acute Myeloid Leukemia

PIM-1L Kinase Binds to and Inactivates SRPK1: A Biochemical and Molecular Dynamics Study

Natural volatiles preventing mosquito biting: an integrated screening platform for accelerated discovery of ORco antagonists

Polymorphic positions 349 and 725 of the autoimmunity-protective allotype 10 of ER aminopeptidase 1 are key in determining its unique enzymatic properties

09 Nov, 2024

Study Finds Early TNF Inhibitor Treatment Is Associated with Higher Heart Disease Risk in Ankylosing Spondylitis Patients — with Caveats

November 8, 2022 sarah JonasResearch Results

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found that early initiation of tumor necrosis factor (TNF) inhibitors was associated with higher risk of heart disease in patients diagnosed with ankylosing spondylitis.